Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) Other Operating Expenses (2016 - 2025)

Collegium Pharmaceutical (COLL) has 5 years of Other Operating Expenses data on record, last reported at $67.6 million in Q4 2025.

  • For Q4 2025, Other Operating Expenses rose 2420.56% year-over-year to $67.6 million; the TTM value through Dec 2025 reached $32.5 million, up 1214.04%, while the annual FY2025 figure was $283.6 million, 9833.05% up from the prior year.
  • Other Operating Expenses reached $67.6 million in Q4 2025 per COLL's latest filing, up from -$10.9 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $67.6 million in Q4 2025 and bottomed at -$14.1 million in Q1 2025.